To advance through public policy and advocacy activities the development of new antimicrobial agents where unmet need exists and the reduction of the occurrence of antimicrobial resistance; to make recommendations to the Board of Directors about how the Society can best further policy and advocacy efforts in these areas; to prioritize for government relations staff the federal funding needs; and to serve as IDSA’s primary point of contact for matters under its charge with Congress and the relevant federal agencies represented.
Amanda JezekSenior Vice President, Public Policy & Government Relations(703) 740-4790Fax: (866) 899-7319
Colin McGoodwinProgram Officer for Public Health Policy(703) 299-0015Fax: (866) 899-7319
To monitor, develop and make recommendations to address issues related to infectious disease clinical practice; to monitor and make recommendations to address issues relating to the practice of hospital epidemiology and infection control; to monitor and advocate with Medicare and other third party payers appropriate coverage and reimbursement for infectious disease services; to develop and make recommendations on providing products and services to improve the practice efficiency of infectious disease clinicians; to identify and suggest clinicians to serve on other committees, task forces, work groups and panels convened to develop practice guidelines; and to make recommendations on activities/issues under its purview that involve federal legislation or regulation.
Ann T. MacIntyre, MD
Andres RodriguezVice President, Clinical Affairs(703) 299-5146Fax: (877) 229-0312
Kay Moyer Program Officer, Clinical Affairs(703) 299-0430Fax: (877) 229-0312
To oversee issues related to the accreditation of all IDSA CME activities, along with IDSA’s re-accreditation process; to review and evaluate all of IDSA’s CME activities to ensure compliance with ACCME regulations and criteria, to include the development of improved assessment modalities to comply with new outcomes-oriented requirements; and to assist and guide future IDSA ACCME re-accreditation processes, to include obtaining accreditation with commendation and a six year accreditation in the next re-accreditation cycle.
To use public policy and advocacy to advance research and development of infectious diseases diagnostics and their appropriate integration into clinical care; to provide education on new developments in diagnostics, the appropriate use and interpretation of their results, and their use in clinical care to optimize patient care outcomes; and to serve as a point of contact for diagnostics with Congress and relevant federal agencies, non-government organizations, and international entities.
Kimberly E. Hanson, MD, MHS
Jaclyn Levy Program Officer for Science & Research Policy(703) 299-1216Fax: (866) 899-7319
Colin McGoodwinProgram Officer for Public Health Policy(703) 299-0015Fax: (866) 899-7319
To develop and make recommendations on the development of any new educational meeting, program, or services for members; to establish an ongoing process to get feedback from the membership on their educational needs; to oversee the Society’s efforts to maintain ACCME accreditation; to monitor developments with respect to post-graduate education in infectious diseases; to monitor developments with respect to certification and recertification in infectious diseases; and to make recommendations for activities/issues under its purview that involve federal legislation or regulation.
To serve as an advisory group responsible for providing input from a young ID professionals’ perspective to inform IDSA initiatives and committee deliberations; foster fellow, resident and medical student participation and membership in IDSA; and provide feedback on issues related to fellowship training.
To oversee the management of Society’s financial reserves and investments; to review operating budget trends; and to make recommendations to the Board of Directors on investment policies and broad financial policies relating to the maintenance of appropriate financial reserves.
Edward T. Ryan, MD, FIDSA
To promote evidence-based, robust U. S. led policy responses to global infectious disease threats, including HIV, tuberculosis, antimicrobial resistance, emerging and resurgent infectious diseases like Ebola, Zika, Dengue, Chikungunya, globally neglected epidemics such as Hepatitis C, and global health security and public health preparedness activities. Advise policymakers about policy and funding needs related to research and development and responses for global infectious diseases that constitute public health threats, including outbreak responses.
Thomas Quinn, MD, FIDSA
Rabita AzizPolicy Research Coordinator(703) 740-4955Fax: (866) 536-6638
To establish and maintain communication with all infectious diseases academic units with accredited training programs in infectious diseases; to assist training directors, in a manner that is mutually beneficial, with any or all facets of the training program curriculum. Such activities may include, but are not limited to, recruitment to the field of infectious diseases, logistics of candidate selection, curriculum requirements and interaction with organizations responsible for curriculum accreditation requirements and board certification.
Emily A. Blumberg, MD, FIDSA
Rachel ShnekendorfDirector of Education(703) 299-0879Fax: (866) 579-0939
To oversee the process to solicit candidates for elected offices and director positions; to present a candidate slate to the Board of Directors for approval with the objective of having the elected leadership generally reflect the diversity of the membership; and to make recommendations to the Board of Directors on the nominations and election process.
To monitor and make recommendations regarding federal support for domestic and global infectious disease issues; to monitor developments and make recommendations related to childhood and adult immunizations; to monitor and make recommendations related to federal support for the public health infrastructure; to monitor developments related to emerging pathogens and to establish ongoing methods to keep members informed in a timely fashion about important developments; to monitor developments and make recommendations to address antimicrobial resistance; and to make recommendations on activities/issues under its purview that involve federal legislation and regulations
Matthew Zahn, MD
To oversee the publication of the Society's scientific journals; to report to the Board of Directors, at least annually, regarding the editorial and financial status of the journals; and to make recommendations to the Board of Directors on substantive editorial policy issues and financial matters.
Susan L. Koletar, MD, FIDSA
Vice President, Communications(703) 299-0201Fax: (866) 889-7614
To promote valid performance measures that IDSA members can implement to improve patient care outcomes in infectious diseases; to monitor and respond to the activities and policies of the federal agencies and key organizations involved in quality improvement and performance measurement; to investigate the feasibility of developing a registry for members to report and compare results on standard measures of patient care and outcomes; to provide both online and in-person (via IDWeek) educational resources that will inform IDSA members about quality improvement in general and applicable performance measures; and to approach quality measurement of ID clinical care in a manner that promotes the value of ID specialists to the broader health care system.
Ron Nahass, MD, FIDSA
Andres RodriguezVice President, Clinical Affairs(703) 299-5146Fax: (877) 299-0312
Thomas KimClinical Affairs, Program Officer(703) 638-1502Fax: (877) 299-0312
To make recommendations to promote research and new advancements in infectious diseases; to monitor developments and make recommendations related to federal support for biomedical research; and to make recommendations on activities/issues under its purview that involve federal legislation and regulation.
Ebbing Lautenbach, MD, FIDSA
To oversee the Society’s recognition awards program, including working with staff to solicit Society award nominees from the membership; and to recommend to the Board of Directors recipients for the awards.
Trenita OnleyMembership and Database Manager(703) 299-0566 Fax: (866) 889-7318
To make recommendations and oversee the development of evidence based clinical practice guideline or any other standard setting documents including those in collaboration with other groups; and to monitor, develop and make recommendations to establish scientific policy on infectious diseases related issues.
Dean L. Winslow, MD, FIDSA
Chris Busky CEO, CAE (703) 638-1503 Fax: (703) 299-0204
Antimicrobial Resistance CommitteeClinical Affairs CommitteeCME SubcommitteeDiagnostics CommitteeEducation CommitteeFellows SubcommitteeFinance CommitteeGlobal Health CommitteeID Training Program Directors CommitteeNominations CommitteePublic Health CommitteePublications CommitteeQuality Improvement CommitteeResearch CommitteeSociety Awards CommitteeStandards & Practice Guidelines Committee
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2017 Infectious Diseases Society of America